Evaluation of different methods of providing medication-related education to patients following myocardial infarction

Canadian Pharmacists Journal

Volumn 141, Issue 4, 2008, Pages 241-247

  Polack, Jolene ^a   Jorgenson, Derek ^a   Robertson, Patrick ^a  

^a SASKATOON HEALTH REGION   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INFORMATION; DRUG SAFETY; FEMALE; HEALTH EDUCATION; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MALE; NURSING CARE; PATIENT ATTITUDE; PATIENT CARE; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHARMACIST ATTITUDE; RANDOMIZED CONTROLLED TRIAL; RECALL; REVIEW; TREATMENT RESPONSE;

EID: 55349120867     PISSN: 17151635     EISSN: None     Source Type: Journal    
DOI: 10.3821/1913-701X(2008)141[241:EODMOP]2.0.CO;2     Document Type: Review

References (21)

1. Antman EM, Anbe DT, Armstrong PW, et al.; American College of Cardiology; American Heart Association; Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004;44:671-719.
2. Chan BTB, Bossart BD, Hudema NRL, et al. Improving the quality of heart attack care in Saskatchewan: outcome and secondary prevention. Saskatoon, SK: Health Quality Council; 2004.
3. Pilote L, Beck CA, Karp I, et al.; Canadian Cardiovascular Outcomes Research Team. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000. Can J Cardiol 2004;20:61-7.
4. Ho PM, Sperus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006;166:1842-7.
5. Wei L, Wang J, Thompson P, et al. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart 2002;88:229-33.
6. 2005/06 Annual Report. Hospital Pharmacy in Canada. Available:www.lillyhospitalsurvey.ca/hpc2/content/2006_report/ 2005_06_full2.pdf (accessed April 29, 2008).
7. Bond CA, Raehl CL, Patry R. Evidence-based core clinical pharmacy services in United States hospitals in 2020: services and staffing. Pharmacotherapy 2004;24:427-40.
8. Williford SL, Johnson DF. Impact ofpharmacist counselling on medication knowledge and compliance. Mil Med 1995;160:561-4.
9. Al-Rashed SA, Wright DJ, Roebuck N, et al. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol 2002;54:657-64.
10. Samoy LJ, Zed PJ, Wilbur K, et al. Drug-related hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study. Pharmacotherapy 2006;26:1578-86.
11. Forster AJ, Clark HD, Menard A, et al. Adverse events among medical patients after discharge from hospital. CMAJ 2004; 170:345-9.
12. MacKeigan LD, Papastavros T, Rajroop J, et al. A pharmacistled interdisciplinary model of medication management support for elderly home care clients. Can Pharm J 2004;137(5):25.
13. Zermansky AG, Petty DR, Raynor DK, et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001;323:1340-3.
14. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47:555-67.
15. Phatak HM, Thomas J 3rd. Relationships between beliefs about medication and nonadherence to prescribed chronic medications. Ann Pharmacother 2006;40:1737-42.
16. Erickson SR, Coombs JH, Kirking DM, et al. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Ann Pharmacother 2001;35:997-1003.
17. Morisky DE, Green I_W, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
18. Shalansky SL Levy AR, Ignaszewski AP. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 2004;38:1363-8.
19. Peterson GM, Fitzmaurice KD, Naunton M, et al. Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy. J Clin Pharm Ther 2004;29:23-30.
20. Stewart S, Vandenbroek AJ, Pearson S, et al. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patient with congestive heart failure. Arch Intern Med 1999;159:257-61.
21. Pearson S, Inglis SC, McLennan SN, et al. Prolonged effects of a home-based intervention in patients with chronic illness. Arch Intern Med 2006;166:645-50.